C-X-C motif chemokine ligand 9 (CXCL9), C-X-C motif chemokine ligand 10 (CXCL10), and C-X-C motif chemokine ligand 11 (CXCL11) (CXCL9/CXCL10/CXCL11)

C-X-C motif chemokine ligand 9 (CXCL9), CXCL10, and CXCL11 are a group of pro-inflammatory cytokines that serve as the primary ligands for the G protein-coupled receptor CXCR3 (UniProt P49682). These chemokines are strongly induced by interferon-gamma (IFN-gamma) and are produced by various cell types, including monocytes, endothelial cells, and fibroblasts (PMID: 21849401). Their primary biological role is to direct the chemotaxis of Th1-type CD4+ T cells, CD8+ T cells, and natural killer (NK) cells to sites of infection, injury, or malignancy (PMID: 25712153). In autoimmune conditions such as rheumatoid arthritis and inflammatory bowel disease, the overproduction of these chemokines drives chronic inflammation and tissue damage (PMID: 28273817). In the context of cancer, they often facilitate the recruitment of tumor-infiltrating lymphocytes, which can enhance the efficacy of immunotherapies, though they may also influence angiogenesis (PMID: 30619100). Therapeutic strategies targeting this axis include monoclonal antibodies like eldelumab, which specifically neutralizes CXCL10, and small-molecule antagonists that block the CXCR3 receptor (PMID: 26351881). Monitoring the levels of these chemokines in serum or tissue is often used as a biomarker for interferon activity and treatment response in various inflammatory diseases. Because they are critical for host defense, therapeutic inhibition of these ligands carries potential risks of increased susceptibility to certain viral or bacterial infections.

Other names

Monokine induced by gamma interferonMIGInterferon gamma-induced protein 10IP-10Interferon-inducible T-cell alpha chemoattractantI-TACSmall-inducible cytokine B9Small-inducible cytokine B10Small-inducible cytokine B11

Neutralization of pro-inflammatory chemokine ligands to prevent their binding to the CXCR3 receptor, thereby inhibiting the recruitment of Th1-type immune cells to inflamed tissues.